Founded in 2014 by orthopedic surgeon Steven Goldberg, MD, Catalyst has set ourselves apart with an unwavering dedication to make shoulder replacements less invasive, with fewer complications and a more natural-feeling shoulder after surgery. Whether through total shoulder replacements, reverse shoulder arthroplasty, or other innovative procedures, we strive to advance techniques and devices for orthopedic surgery to maximize outcomes for patients, surgeons and the broader healthcare system.
PURPOSEFULLY DESIGNED™
We’re advancing the world of shoulder arthroplasty.
Experience what sets us apart.
DR. STEVEN GOLDBERG
OUR VISION
The company fanatical about redefining and elevating shoulder restoration.
OUR MISSION
Putting surgeons and their patients first every day.
OUR QUALITY POLICY
Our pledge at Catalyst OrthoScience is to deliver the highest quality medical devices that will meet or exceed the expectations of our customers, meet regulatory requirements and demonstrate our commitment to excellence.
As part of this commitment, Catalyst OrthoScience will strive to continually improve the safety and efficacy of our products through an effective quality management system.
JOIN THE TEAM
If you’re ready to help us lead the evolution of shoulder arthroplasty, we’re ready for you.
SEE OPEN POSITIONS
NEWS
Catalyst OrthoScience Announces Settlement of Patent Litigation with Shoulder Innovations
Agreement enables continued focus on differentiated innovation, growing adoption, and surgeon partnership NAPLES, Fla., Sept. 9, 2026 - Catalyst OrthoScience Inc. (“Catalyst”), a private medical device technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced that it has entered into a settlement agreement with Shoulder Innovations, Inc. (“Shoulder…
Read More
Catalyst OrthoScience Appoints Gordon Van Ummersen to Board of Directors
Medtech leader with deep orthopedic extremities experience enhances board depth as shoulder-focused company advances growth and strategic objectives NAPLES, Fla., May 13, 2026 - Catalyst OrthoScience Inc. (“Catalyst”), a private medical device technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced the appointment of Gordon Van Ummersen to…
Read More
Catalyst Fracture System Wins Medical Device Engineering Breakthrough Designation in 2026 MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide NAPLES, Fla., – May 7, 2026 – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced that the Catalyst Fracture System received the “Medical Device…
Read More
1000-0002-A